These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

245 related items for PubMed ID: 5591779

  • 21. [The thyroid dose in radioiodine uptake. Critical analysis of estimation methods].
    Buraggi GL.
    Radiobiol Radioter Fis Med; 1966; 21(1):41-54. PubMed ID: 5934741
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. [Radioisotope therapy of hyperthyroidism].
    Englaro GC, Zecchin R.
    Minerva Med; 1973 Apr 18; 64(25):1347-56. PubMed ID: 4740096
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. [Studies on 131-I treatment of hyperthroidism. 1. Factors related to the effectiveness of 131-I treatment].
    Konishi J.
    Naika Hokan; 1970 Oct 18; 17(10):313-27. PubMed ID: 5529419
    [No Abstract] [Full Text] [Related]

  • 28. Relation between the 6- and 24-hour thyroidal 131-I uptake and the control of thyrotoxicosis by radioactive 131-I therapy.
    Sagel J, Epstein S, Jackson WP.
    S Afr Med J; 1973 Aug 04; 47(30):1356-8. PubMed ID: 4721494
    [No Abstract] [Full Text] [Related]

  • 29. Study of possible factors inducing hypothyroidism after I-131 treatment in hyperthyroidism.
    Chen FW.
    Taiwan Yi Xue Hui Za Zhi; 1969 Feb 28; 68(2):63-79. PubMed ID: 5257433
    [No Abstract] [Full Text] [Related]

  • 30. Plasma thyrotropin levels in patients treated with radioiodine for hyperthyroidism.
    Tubiana M, Freychet P, Perez R, Di Paola R.
    Rev Eur Etud Clin Biol; 1971 Dec 28; 16(10):1006-10. PubMed ID: 5139838
    [No Abstract] [Full Text] [Related]

  • 31. [1st results of weak-dose radioiodine therapy in the treatment of hyperthyroidism].
    Alland A, Simonin R, Ricciardi R, Paulin R, Felix J.
    Mars Med; 1968 Dec 28; 105(11):831-4. PubMed ID: 5746232
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. [Radioiodine treatment of hyperthyroidism using a simplified dosimetric approach. Clinical results].
    Giovanella L, De Palma D, Ceriani L, Vanoli P, Garancini S, Tordiglione M, Tarolo GL.
    Radiol Med; 2000 Dec 28; 100(6):480-3. PubMed ID: 11307510
    [Abstract] [Full Text] [Related]

  • 34. Late results of fractionated radioiodine therapy. Follow-up studies of hyperthyroidism after 2 to 11 years.
    Reinwein D, Miss H, Horster FA, Berger H, Klein E, Oberdisse K.
    Ger Med Mon; 1969 May 28; 14(5):234-8. PubMed ID: 5807507
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. I-131 treatment of hyperthyroidism. Analysis of 369 cases treated with an initial dose of 15 MC or less.
    Yang HF.
    Nagoya J Med Sci; 1972 Mar 28; 34(4):267-81. PubMed ID: 4665961
    [No Abstract] [Full Text] [Related]

  • 38. Early manifestation of anaplastic thyroid cancer after radioiodine treatment for toxic nodular goitre.
    Nĕmec J, Niederle B, Cenková V, Vána S, Zeman V.
    Neoplasma; 1971 Mar 28; 18(3):325-33. PubMed ID: 5093952
    [No Abstract] [Full Text] [Related]

  • 39. [Results of radioiodine treatment in hyperthyroidism].
    Saito S, Sakurada T, Tayama S, Yamamoto M, Osari K.
    Saishin Igaku; 1971 Jul 28; 26(7):1358-65. PubMed ID: 5092386
    [No Abstract] [Full Text] [Related]

  • 40. [The state of the peripheral blood and bone marrow in patients with diffuse toxic goiter during radioiodine therapy].
    Dozorets IuL, Perlin MS, Popova LI, Eĭdel' II.
    Med Radiol (Mosk); 1967 Apr 28; 12(4):41-4. PubMed ID: 6052182
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 13.